ELUT

Elutia Inc. (NASDAQ:ELUT) is a commercial-stage biotechnology company founded in 2015 and headquartered in Silver Spring, Maryland. Originally incorporated as Aziyo Biologics, the company rebranded to Elutia in September 2023. The company went public in October 2020 and specializes in developing and commercializing drug-eluting biologics products for critical medical applications including cardiac device protection, wound care, and breast reconstruction. Elutia operates through three main business segments: Device Protection, Women's Health, and Cardiovascular, serving hospitals and healthcare facilities across the United States through direct sales forces, independent agents, and distributors.